UK Markets open in 1 hr 32 mins

NVO Nov 2022 75.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.15000.0000 (0.00%)
As of 01:40PM EDT. Market open.
Full screen
Previous close2.1500
Open2.1500
Bid0.6000
Ask2.6500
Strike75.00
Expiry date2022-11-18
Day's range2.1500 - 2.3000
Contract rangeN/A
VolumeN/A
Open interest10
  • Zacks

    4 Large Drug Stocks to Watch as the Industry Recovers

    Drug/biotech companies are likely to see significant advances in innovation in 2022. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Glaxo (GSK) are worth retaining in your portfolio.

  • Globe Newswire

    Novo Nordisk A/S: Share repurchase programme

    Bagsværd, Denmark, 16 May 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme initiate

  • Zacks

    Lilly's (LLY) Diabetes Treatment Tirzepatide Gets FDA Nod

    Lilly's (LLY) Mounjaro (tirzepatide) is a novel diabetes treatment, which has shown impressive blood sugar reductions and weight loss in a broad range of type II diabetes patients in the SURPASS studies.